Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

University of Leiden

www.leiden.edu

Latest From University of Leiden

Recent Dealmaking (06/2004)

Summarizing the month in European dealmaking.

Anosys Inc.

As a former head of discovery research at Rhone-Poulenc Rorer Inc. (now Aventis SA), Jean-Bernard Le Pecq, PhD was accustomed to learning of new discoveries on a regular basis. But in 1997, one particular breakthrough in cell-to-cell communications caught his attention. Researchers found that small vesicles, known as exosomes, allow for the transfer of proteins to other cells. Le Pecq believed that exosomes could be used as a mechanism to develop innovative therapeutic vaccines and this idea ultimately propelled him to co-found Anosys Inc. in 1997.
BioPharmaceutical Business Strategies

Medical Device Start-ups in Europe--The New Entrepreneurs

Device start-ups are still rare in Europe. But now a combination of factors--new venture money, more receptive public markets, and a new generation of entrepreneurs--is making device company creation less exotic.
Medical Device Europe

IsoTis BV

Uniting engineering with biology is the aim of IsoTis BV. The start-up has a portfolio of 33 patents all related to what the company terms "substitution medicine", the replacement or repair of human tissue.
Medical Device Strategy
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register